discovery of glp-1 receptor assay: drug in the metabolic field Machine-Learning-Guided Peptide Drug Discovery: Development

A.SchitoG

The persistent difficulty in regulating food intake has contributed to the increasing acceptance of uncontrolled eating qualifying as an addiction disorder, similar to established models of drug abuse

Val8-glucagon-like peptide-1 protects against Abeta1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats

Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed for chronic weight management in adults with obesity or overweight with weight-related comorbidities

We provide Ashwagandha as KSM-66, the most scientifically supported form, containing a high concentration of active compounds from the root-only

Our findings suggest that GLP-1s could serve as an adjunctive therapy for HS patients, especially those with metabolic comorbidities, Neal Gupta, MD, a resident at SUNY Downstate Health Sciences University, told Healio